Amarin's REDUCE-IT Data For Vascepa May Be Game-Changing, But Not Without Controversy

CVOT results for Amarin's fish-oil pill show an unprecedented reduction in cardiovascular deaths. While questions have been raised about an LDL increase in the placebo group, an investigator says the overall results are too good to be explained by a well-known mineral oil effect.